Clinical TrialID 4830

Comparison Study of Liquid and Lyophilized Formulations of Subcutaneous Tetrodotoxin (TTX) in Healthy Volunteers

NCT01527734

Healthy

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
4830
Evidence Id
4830
Core Evidence Id
4830
Source Clinical Trial Id
4805
Herb2 Clinical Trial Id
HBCT004805
Nct Id
NCT01527734
Title
Comparison Study of Liquid and Lyophilized Formulations of Subcutaneous Tetrodotoxin (TTX) in Healthy Volunteers
Status
Completed
Phase
Phase 1
Study Result
No
Study Condition
Healthy
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: SCREENING
Intervention
DRUG: Tetrodotoxin|DRUG: placebo
Intervention Allocation
Randomized
Intervention Model
Crossover
Intervention Mask
Quadruple
Intervention Purpose
Screening
Gender
All
Age
Adult
Enrollment
44
Outcome Measure
Compare plasma and urine PK profiles of TTX following doses of Lyophilized and Injectable Liquid TTX, PK timepoints occurred at 0,0.33,0.67,1, 1.5,2,4,6,8,10,12,14 and 24 hours after first dose on Days 1 \& 2. Liquid and Lyophilized formulations will be assessed using ANOVA of the T-R ratio based on log-transformed AUC and Cmax values., 26 timepoints over 48 hours
Sponsor Collaborator
Wex Pharmaceuticals Inc.
Funded By
INDUSTRY
Location
Comprehensive Clinical Research, Tacoma, Washington, 98418, United States
Other Id
TTX-CINP-201PK
Start Date
2011-12
Primary Completion Date
2012-01
Completion Date
First Posted
2012-02-07
Results First Posted
Last Update Posted
2012-02-08
Study Document
Study Url
https://clinicaltrials.gov/study/NCT01527734
Title Cn
Title En
Comparison Study of Liquid and Lyophilized Formulations of Subcutaneous Tetrodotoxin (TTX) in Healthy Volunteers
Bilingual Status
semi_complete